JP2019512210A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019512210A5 JP2019512210A5 JP2018540833A JP2018540833A JP2019512210A5 JP 2019512210 A5 JP2019512210 A5 JP 2019512210A5 JP 2018540833 A JP2018540833 A JP 2018540833A JP 2018540833 A JP2018540833 A JP 2018540833A JP 2019512210 A5 JP2019512210 A5 JP 2019512210A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cdr
- domains
- domain
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021139610A JP7358426B2 (ja) | 2016-02-05 | 2021-08-30 | Ｅｇｆｌ６特異的モノクローナル抗体及びそれらの使用方法 |
| JP2023106822A JP2023130411A (ja) | 2016-02-05 | 2023-06-29 | Ｅｇｆｌ６特異的モノクローナル抗体及びそれらの使用方法 |
| JP2024140677A JP2024164139A (ja) | 2016-02-05 | 2024-08-22 | Ｅｇｆｌ６特異的モノクローナル抗体及びそれらの使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662291987P | 2016-02-05 | 2016-02-05 | |
| US62/291,987 | 2016-02-05 | ||
| PCT/US2017/016659 WO2017136807A1 (en) | 2016-02-05 | 2017-02-06 | Egfl6 specific monoclonal antibodies and methods of their use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021139610A Division JP7358426B2 (ja) | 2016-02-05 | 2021-08-30 | Ｅｇｆｌ６特異的モノクローナル抗体及びそれらの使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019512210A JP2019512210A (ja) | 2019-05-16 |
| JP2019512210A5 true JP2019512210A5 (enExample) | 2020-03-12 |
Family
ID=59501106
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018540833A Pending JP2019512210A (ja) | 2016-02-05 | 2017-02-06 | Ｅｇｆｌ６特異的モノクローナル抗体及びそれらの使用方法 |
| JP2021139610A Active JP7358426B2 (ja) | 2016-02-05 | 2021-08-30 | Ｅｇｆｌ６特異的モノクローナル抗体及びそれらの使用方法 |
| JP2023106822A Pending JP2023130411A (ja) | 2016-02-05 | 2023-06-29 | Ｅｇｆｌ６特異的モノクローナル抗体及びそれらの使用方法 |
| JP2024140677A Ceased JP2024164139A (ja) | 2016-02-05 | 2024-08-22 | Ｅｇｆｌ６特異的モノクローナル抗体及びそれらの使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021139610A Active JP7358426B2 (ja) | 2016-02-05 | 2021-08-30 | Ｅｇｆｌ６特異的モノクローナル抗体及びそれらの使用方法 |
| JP2023106822A Pending JP2023130411A (ja) | 2016-02-05 | 2023-06-29 | Ｅｇｆｌ６特異的モノクローナル抗体及びそれらの使用方法 |
| JP2024140677A Ceased JP2024164139A (ja) | 2016-02-05 | 2024-08-22 | Ｅｇｆｌ６特異的モノクローナル抗体及びそれらの使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10875912B2 (enExample) |
| EP (1) | EP3411070A4 (enExample) |
| JP (4) | JP2019512210A (enExample) |
| KR (1) | KR20180105704A (enExample) |
| CN (2) | CN113912717B (enExample) |
| AU (2) | AU2017214685B2 (enExample) |
| BR (1) | BR112018015826A2 (enExample) |
| CA (2) | CA3012696C (enExample) |
| MX (1) | MX2018009499A (enExample) |
| SG (1) | SG11201806622PA (enExample) |
| WO (1) | WO2017136807A1 (enExample) |
| ZA (1) | ZA201805051B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017214685B2 (en) * | 2016-02-05 | 2024-03-07 | The Board Of Regents Of The University Of Texas System | EGFL6 specific monoclonal antibodies and methods of their use |
| KR102737830B1 (ko) * | 2017-10-01 | 2024-12-03 | 타이페이 메디컬 유니이버시티 | 항-egf 유사 도메인 다중 6(egfl6) 항체 및 암 진단 및 치료에서 이의 적용 |
| WO2020141145A1 (en) * | 2018-12-30 | 2020-07-09 | F. Hoffmann-La Roche Ag | Anti-rabbit cd19 antibodies and methods of use |
| CN110951733A (zh) * | 2019-11-27 | 2020-04-03 | 山西医科大学 | 一种靶向抑制食管癌EGFL6基因表达的siRNA及构建的表达载体和应用 |
| CN116381251B (zh) * | 2023-03-13 | 2024-06-25 | 柏定生物工程(北京)有限公司 | 一种肿瘤标志物诊断试剂盒及其诊断方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1845108A3 (en) | 1994-07-29 | 2007-10-24 | Innogenetics N.V. | Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| US20030036508A1 (en) | 1997-11-22 | 2003-02-20 | John Ford | EGF motif protein, EGFL6 materials and methods |
| CA2425833A1 (en) | 2000-10-13 | 2002-04-18 | Hyseq, Inc. | Egf motif protein, egfl6 materials and methods |
| CN101360823A (zh) * | 2005-11-24 | 2009-02-04 | 财团法人阪大微生物病研究会 | 重组多价疫苗 |
| AR059851A1 (es) | 2006-03-16 | 2008-04-30 | Genentech Inc | Anticuerpos de la egfl7 y metodos de uso |
| KR20180005753A (ko) * | 2008-06-25 | 2018-01-16 | 에스바테크 - 어 노바티스 컴파니 엘엘씨 | Ｖｅｇｆ를 억제하는 안정하고 가용성인 항체 |
| WO2011137334A1 (en) * | 2010-04-30 | 2011-11-03 | The Research Foundation Of State University Of New York | Compositions and methods for stimulating immune response against moraxella catarrhalis |
| AU2012310328A1 (en) | 2011-09-23 | 2014-04-10 | Technophage, Investigação E Desenvolvimento Em Biotecnologia, S.A. | Anti-Tumor Necrosis Factor-alpha agents and uses thereof |
| WO2014150720A1 (en) * | 2013-03-15 | 2014-09-25 | The Regents Of The University Of Michigan | Compositions and methods relating to inhibiting cancer cell growth and/or proliferation |
| CA2913052A1 (en) | 2013-05-24 | 2014-11-27 | Board Of Regents, The University Of Texas System | Chimeric antigen receptor-targeting monoclonal antibodies |
| AU2017214685B2 (en) * | 2016-02-05 | 2024-03-07 | The Board Of Regents Of The University Of Texas System | EGFL6 specific monoclonal antibodies and methods of their use |
-
2017
- 2017-02-06 AU AU2017214685A patent/AU2017214685B2/en active Active
- 2017-02-06 MX MX2018009499A patent/MX2018009499A/es unknown
- 2017-02-06 KR KR1020187024950A patent/KR20180105704A/ko not_active Ceased
- 2017-02-06 US US16/075,711 patent/US10875912B2/en active Active
- 2017-02-06 JP JP2018540833A patent/JP2019512210A/ja active Pending
- 2017-02-06 CN CN202110985801.8A patent/CN113912717B/zh active Active
- 2017-02-06 WO PCT/US2017/016659 patent/WO2017136807A1/en not_active Ceased
- 2017-02-06 CN CN201780015519.9A patent/CN109562163B/zh active Active
- 2017-02-06 SG SG11201806622PA patent/SG11201806622PA/en unknown
- 2017-02-06 BR BR112018015826-7A patent/BR112018015826A2/pt not_active Application Discontinuation
- 2017-02-06 CA CA3012696A patent/CA3012696C/en active Active
- 2017-02-06 EP EP17748334.4A patent/EP3411070A4/en active Pending
- 2017-02-06 CA CA3298267A patent/CA3298267A1/en active Pending
-
2018
- 2018-07-26 ZA ZA2018/05051A patent/ZA201805051B/en unknown
-
2020
- 2020-11-12 US US17/096,280 patent/US12152071B2/en active Active
-
2021
- 2021-08-30 JP JP2021139610A patent/JP7358426B2/ja active Active
-
2023
- 2023-06-29 JP JP2023106822A patent/JP2023130411A/ja active Pending
-
2024
- 2024-05-29 AU AU2024203614A patent/AU2024203614A1/en active Pending
- 2024-08-22 JP JP2024140677A patent/JP2024164139A/ja not_active Ceased
- 2024-10-18 US US18/920,268 patent/US20250145702A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112020015479A2 (pt) | Anticorpos anticlaudina 18.2 e usos dos mesmos | |
| JP2020501531A5 (enExample) | ||
| JP2022515318A5 (enExample) | ||
| JP2019509976A5 (enExample) | ||
| JP2013502913A5 (enExample) | ||
| CN111278861A (zh) | Pd-l1抗体、其抗原结合片段及医药用途 | |
| JP2026041845A5 (enExample) | ||
| JP2019535250A5 (enExample) | ||
| RU2016111015A (ru) | НУКЛЕИНОВЫЕ КИСЛОТЫ, КОДИРУЮЩИЕ АНТИТЕЛА ПРОТИВ СИАЛИРОВАННОГО АНТИГЕНА ЛЬЮИСАа ЧЕЛОВЕКА | |
| JP2019502405A5 (enExample) | ||
| JP2010535713A5 (enExample) | ||
| JP2012519492A5 (enExample) | ||
| RU2014101669A (ru) | Агенты, связывающие белки r-спондины (rspo), и способы их применения | |
| JP2018512175A5 (enExample) | ||
| JP2017535257A5 (enExample) | ||
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| JP2023543493A5 (enExample) | ||
| JP2022512891A5 (enExample) | ||
| CN103025760A (zh) | 人源化egfr抗体 | |
| JP2024016024A5 (enExample) | ||
| CN116940598A (zh) | 用于治疗表达cldn18.2的实体瘤的cldn18.2/cd3双特异性抗体 | |
| JP2025507817A5 (enExample) | ||
| US20250034275A1 (en) | Anti-trop-2 antibody or antigen-binding fragment thereof | |
| JP2022521305A (ja) | 抗ｐｄ－ｌ１抗体及びその使用 | |
| WO2024113099A1 (en) | Protease cleavable recombinant bispecific antibodies and compositions and uses thereof |